Now recruiting patients with ulcers for a study supported by NHS England

Contact us if your ulcer is less than 6 weeks old and you live in South-East England

Goal is to determine patient and economic benefits of using Acapsil as first-line treatment at GP-surgeries. Acapsil is already approved and available for sale over-the-counter.

To participate, your venous leg ulcers or diabetic foot ulcers must be less than 6 weeks old.
You must live in Hampshire, East Dorset, West Surrey, Berkshire or the western part of West Sussex.

Goal is to determine patient and economic benefits of using Acapsil as first-line treatment at GP-surgeries. Acapsil is already approved and available for sale over-the-counter.

To participate, your venous leg ulcers or diabetic foot ulcers must be less than 6 weeks old.
You must live in Hampshire, East Dorset, West Surrey, Berkshire or the western part of West Sussex.

60% quicker
than antibiotics

at removing infection

at removing infection

at removing infection

Passive Immunotherapy

Acting via the skin microbiome

Acting via the skin microbiome

Acting via the skin microbiome

Removes pain,
smell and discharge

by efficiently removing the infection

by efficiently removing the infection

by efficiently removing the infection

Less Scarring

"Where I have used Acapsil the scarring is flat, whereas the older scars are hypertrophic." ST

"Where I have used Acapsil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic." ST

"Where I have used Acapsil the scarring is flat against the surrounding skin, whereas the older scars are bulging / hypertrophic." ST

"Acapsil changed my life."

"From 4 weeks of absolute hell - to being pain-free, getting a full night's sleep and back to normal at work."

"From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work - to being pain-free, getting a full night's sleep and back to normal at work."

"From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work - to being pain-free, getting a full night's sleep and back to normal at work."

NH ( patient)

NH ( patient)

NH ( patient)

Did you know:
killing the microbes in your wound makes YOU resistant!

MPPT removes infection without killing

MPPT removes infection without killing

MPPT removes infection without killing

69.5% Savings

Cost-effectiveness determined in NHS Clinical Audit

Cost-effectiveness determined in NHS Clinical Audit

Cost-effectiveness determined in NHS Clinical Audit

Hypoallergenic

Only natural ingredients

Only natural ingredients

Only natural ingredients

FDA Executive Review:

Antibiotic and antiseptic dressings do not improve wound infections or wound healing.

Antibiotic and antiseptic dressings do not improve wound infections or wound healing.

Antibiotic and antiseptic dressings do not improve wound infections or wound healing.

US FDA 2016

US FDA 2016

US FDA 2016

In connection with publication on MPPT, the

In connection with publication on MPPT, the

In connection with publication on MPPT, the

Chair of WHO Anti-Microbial-Resistance group said:

“AMR is an escalating global threat. We need alternative treatments, including innovative ways to use the body’s own immune system and healthy bacteria.”

“AMR is an escalating global threat. We need alternative treatments, including innovative ways to use the body’s own immune system and healthy bacteria.”

“AMR is an escalating global threat. We need alternative treatments, including innovative ways to use the body’s own immune system and healthy bacteria.”

“For me, this Acapsil open air method is a no brainer. It is easier, no fuss, and obviously cheaper than these expensive dressings.”

VH (patient)

VH (patient)

VH (patient)

previous arrow
next arrow
Slider

Diabetic foot ulcers and venous leg ulcers originate as secondary symptoms of a primary disease process that affects the entire body, i.e. diabetes and cardiovascular disease, respectively.

Among the symptoms of both diseases are ulcers, and in particular diabetic foot ulcers and venous leg ulcers. Both types of ulcers are caused by internal disease processes in the body as opposed to wounds that are typically caused by external factors such as trauma or surgery.

So, the origin of ulcers is to be sought within the body and their emergence is a sign that the disease processes have advanced to the point where the structures and tissue under the ulcerated area are seriously impaired.

That is why the use of MPPT on ulcers may diverge slightly to its use on wounds. MPPT will support the immune system in the fight against undesired colonisation and it will facilitate strong granulation in the ulcerated area. Part of granulation is angiogenesis, i.e. the creation of novel blood vessels. Renewed blood supply enables new tissue formation and thereby healing. This is what is typically seen in all ulcers receiving MPPT.

However, depending on the degree of advancement of the primary disease in the underlying structures, the body will be able to progress to closing the wound or, in advanced cases, the body will make progress at first but the disease will then overpower the newly induced healing progress. This is reflected in a slow-down of the healing and potential reappearance of slough and is the indication that an additional application of MPPT to re-boost the process is desirable.

The experience with MPPT is, that it can continue to support the healing of ulcers in all the disease stages – including non-healing ulcers – until closure. However, the number and frequency of applications are individual to the patient and directly dependent on the degree of advancement of his/her primary disease.

Close Menu
Close Panel